Citation Impact
1 from Science/Nature 59 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Edward Arrowsmith being referenced
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
2016
Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
2013
Author Peers
| Author | Oncology | PRM | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Edward Arrowsmith | 618 | 521 | 538 | 59 | 1.1k | |
| Małgorzata Kruczek | 1 | 2 | 11 | 31 | 423 | |
| Y. Nophar | 156 | 28 | 446 | 10 | 1.1k | |
| Hsiung Chia Tze | 20 | 445 | ||||
| Nasma Hamdi El Najjar | 1 | 3 | 11 | 8 | 400 | |
| M. Inam Jameel | 1 | 52 | 9 | 326 |
All Works
Loading papers...